As of January 22, 2025, Medpace (MEDP) has a market cap of $10.75 billion USD. According to our data, Medpace is ranked No.1568 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $10.75 B |
4.08%
|
Dec 31, 2024 | $10.33 B |
8.38%
|
Dec 29, 2023 | $9.53 B |
44.31%
|
Dec 30, 2022 | $6.60 B |
-2.40%
|
Dec 31, 2021 | $6.76 B |
56.35%
|
Dec 31, 2020 | $4.33 B |
65.60%
|
Dec 31, 2019 | $2.61 B |
58.81%
|
Dec 31, 2018 | $1.65 B |
45.97%
|
Dec 29, 2017 | $1.13 B |
0.53%
|
Dec 30, 2016 | $1.12 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
IQVIA
IQV
|
$37.16 B |
-0.001 M
|
USA
|
ICON plc
ICLR
|
$16.77 B |
0.000 M
|
Ireland
|
Charles River Laboratories
CRL
|
$8.62 B |
0.000 M
|
USA
|
LabCorp
LH
|
$20.24 B |
0.000 M
|
USA
|
Medpace
MEDP
|
$10.75 B |
-0.000 M
|
USA
|
HeartBeam
BEAT
|
$57.60 M |
0.000 M
|
USA
|
Market Cap | = | MEDP Stock Price | * | MEDP Shares Outstanding |
= | $345.80 | * | 31.08 M | |
= | $10.75 B |